Literature DB >> 27479181

Somatic PHF6 mutations in 1760 cases with various myeloid neoplasms.

T Mori1, Y Nagata1, H Makishima1, M Sanada1, Y Shiozawa1, A Kon1, T Yoshizato1, A Sato-Otsubo1, K Kataoka1, Y Shiraishi2, K Chiba2, H Tanaka3, K Ishiyama4, S Miyawaki4, H Mori5, T Nakamaki6, R Kihara7, H Kiyoi7, H P Koeffler8,9, L-Y Shih10, S Miyano2,3, T Naoe7,11, C Haferlach12, W Kern12, T Haferlach12, S Ogawa1, K Yoshida1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27479181     DOI： 10.1038/leu.2016.212

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Mutations in PHF6 are associated with Börjeson-Forssman-Lehmann syndrome.

Authors:  Karen M Lower; Gillian Turner; Bronwyn A Kerr; Katherine D Mathews; Marie A Shaw; Agi K Gedeon; Susan Schelley; H Eugene Hoyme; Susan M White; Martin B Delatycki; Anne K Lampe; Jill Clayton-Smith; Helen Stewart; Conny M A van Ravenswaay; Bert B A de Vries; Barbara Cox; Markus Grompe; Shelley Ross; Paul Thomas; John C Mulley; Jozef Gécz
Journal:  Nat Genet       Date:  2002-11-04       Impact factor: 38.330

2.  Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms.

Authors:  Ayana Kon; Lee-Yung Shih; Masashi Minamino; Masashi Sanada; Yuichi Shiraishi; Yasunobu Nagata; Kenichi Yoshida; Yusuke Okuno; Masashige Bando; Ryuichiro Nakato; Shumpei Ishikawa; Aiko Sato-Otsubo; Genta Nagae; Aiko Nishimoto; Claudia Haferlach; Daniel Nowak; Yusuke Sato; Tamara Alpermann; Masao Nagasaki; Teppei Shimamura; Hiroko Tanaka; Kenichi Chiba; Ryo Yamamoto; Tomoyuki Yamaguchi; Makoto Otsu; Naoshi Obara; Mamiko Sakata-Yanagimoto; Tsuyoshi Nakamaki; Ken Ishiyama; Florian Nolte; Wolf-Karsten Hofmann; Shuichi Miyawaki; Shigeru Chiba; Hiraku Mori; Hiromitsu Nakauchi; H Phillip Koeffler; Hiroyuki Aburatani; Torsten Haferlach; Katsuhiko Shirahige; Satoru Miyano; Seishi Ogawa
Journal:  Nat Genet       Date:  2013-08-18       Impact factor: 38.330

3.  Frequent pathway mutations of splicing machinery in myelodysplasia.

Authors:  Kenichi Yoshida; Masashi Sanada; Yuichi Shiraishi; Daniel Nowak; Yasunobu Nagata; Ryo Yamamoto; Yusuke Sato; Aiko Sato-Otsubo; Ayana Kon; Masao Nagasaki; George Chalkidis; Yutaka Suzuki; Masashi Shiosaka; Ryoichiro Kawahata; Tomoyuki Yamaguchi; Makoto Otsu; Naoshi Obara; Mamiko Sakata-Yanagimoto; Ken Ishiyama; Hiraku Mori; Florian Nolte; Wolf-Karsten Hofmann; Shuichi Miyawaki; Sumio Sugano; Claudia Haferlach; H Phillip Koeffler; Lee-Yung Shih; Torsten Haferlach; Shigeru Chiba; Hiromitsu Nakauchi; Satoru Miyano; Seishi Ogawa
Journal:  Nature       Date:  2011-09-11       Impact factor: 49.962

4.  PHF6 regulates cell cycle progression by suppressing ribosomal RNA synthesis.

Authors:  Jiadong Wang; Justin Wai-chung Leung; Zihua Gong; Lin Feng; Xiaobing Shi; Junjie Chen
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

5.  PHF6 mutations in T-cell acute lymphoblastic leukemia.

Authors:  Pieter Van Vlierberghe; Teresa Palomero; Hossein Khiabanian; Joni Van der Meulen; Mireia Castillo; Nadine Van Roy; Barbara De Moerloose; Jan Philippé; Sara González-García; María L Toribio; Tom Taghon; Linda Zuurbier; Barbara Cauwelier; Christine J Harrison; Claire Schwab; Markus Pisecker; Sabine Strehl; Anton W Langerak; Jozef Gecz; Edwin Sonneveld; Rob Pieters; Elisabeth Paietta; Jacob M Rowe; Peter H Wiernik; Yves Benoit; Jean Soulier; Bruce Poppe; Xiaopan Yao; Carlos Cordon-Cardo; Jules Meijerink; Raul Rabadan; Frank Speleman; Adolfo Ferrando
Journal:  Nat Genet       Date:  2010-03-14       Impact factor: 38.330

6.  High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia.

Authors:  Hironori Harada; Yuka Harada; Hiromasa Niimi; Taiichi Kyo; Akiro Kimura; Toshiya Inaba
Journal:  Blood       Date:  2003-11-13       Impact factor: 22.113

7.  A comprehensive molecular study on Coffin-Siris and Nicolaides-Baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered chromatin remodeling.

Authors:  Dagmar Wieczorek; Nina Bögershausen; Filippo Beleggia; Sabine Steiner-Haldenstätt; Esther Pohl; Yun Li; Esther Milz; Marcel Martin; Holger Thiele; Janine Altmüller; Yasemin Alanay; Hülya Kayserili; Ludger Klein-Hitpass; Stefan Böhringer; Andreas Wollstein; Beate Albrecht; Koray Boduroglu; Almuth Caliebe; Krystyna Chrzanowska; Ozgur Cogulu; Francesca Cristofoli; Johanna Christina Czeschik; Koenraad Devriendt; Maria Teresa Dotti; Nursel Elcioglu; Blanca Gener; Timm O Goecke; Malgorzata Krajewska-Walasek; Encarnación Guillén-Navarro; Joussef Hayek; Gunnar Houge; Esra Kilic; Pelin Özlem Simsek-Kiper; Vanesa López-González; Alma Kuechler; Stanislas Lyonnet; Francesca Mari; Annabella Marozza; Michèle Mathieu Dramard; Barbara Mikat; Gilles Morin; Fanny Morice-Picard; Ferda Ozkinay; Anita Rauch; Alessandra Renieri; Sigrid Tinschert; G Eda Utine; Catheline Vilain; Rossella Vivarelli; Christiane Zweier; Peter Nürnberg; Sven Rahmann; Joris Vermeesch; Hermann-Josef Lüdecke; Michael Zeschnigk; Bernd Wollnik
Journal:  Hum Mol Genet       Date:  2013-08-01       Impact factor: 6.150

8.  Clinical and biological implications of driver mutations in myelodysplastic syndromes.

Authors:  Elli Papaemmanuil; Moritz Gerstung; Luca Malcovati; Sudhir Tauro; Gunes Gundem; Peter Van Loo; Chris J Yoon; Peter Ellis; David C Wedge; Andrea Pellagatti; Adam Shlien; Michael John Groves; Simon A Forbes; Keiran Raine; Jon Hinton; Laura J Mudie; Stuart McLaren; Claire Hardy; Calli Latimer; Matteo G Della Porta; Sarah O'Meara; Ilaria Ambaglio; Anna Galli; Adam P Butler; Gunilla Walldin; Jon W Teague; Lynn Quek; Alex Sternberg; Carlo Gambacorti-Passerini; Nicholas C P Cross; Anthony R Green; Jacqueline Boultwood; Paresh Vyas; Eva Hellstrom-Lindberg; David Bowen; Mario Cazzola; Michael R Stratton; Peter J Campbell
Journal:  Blood       Date:  2013-09-12       Impact factor: 22.113

9.  Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.

Authors:  J Nangalia; C E Massie; E J Baxter; F L Nice; G Gundem; D C Wedge; E Avezov; J Li; K Kollmann; D G Kent; A Aziz; A L Godfrey; J Hinton; I Martincorena; P Van Loo; A V Jones; P Guglielmelli; P Tarpey; H P Harding; J D Fitzpatrick; C T Goudie; C A Ortmann; S J Loughran; K Raine; D R Jones; A P Butler; J W Teague; S O'Meara; S McLaren; M Bianchi; Y Silber; D Dimitropoulou; D Bloxham; L Mudie; M Maddison; B Robinson; C Keohane; C Maclean; K Hill; K Orchard; S Tauro; M-Q Du; M Greaves; D Bowen; B J P Huntly; C N Harrison; N C P Cross; D Ron; A M Vannucchi; E Papaemmanuil; P J Campbell; A R Green
Journal:  N Engl J Med       Date:  2013-12-10       Impact factor: 91.245

10.  Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.

Authors:  T Haferlach; Y Nagata; V Grossmann; Y Okuno; U Bacher; G Nagae; S Schnittger; M Sanada; A Kon; T Alpermann; K Yoshida; A Roller; N Nadarajah; Y Shiraishi; Y Shiozawa; K Chiba; H Tanaka; H P Koeffler; H-U Klein; M Dugas; H Aburatani; A Kohlmann; S Miyano; C Haferlach; W Kern; S Ogawa
Journal:  Leukemia       Date:  2013-11-13       Impact factor: 11.528
View more
  11 in total

1.  PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation.

Authors:  Wenbin Xiao; Maheetha Bharadwaj; Max Levine; Noushin Farnhoud; Friederike Pastore; Bartlomiej M Getta; Anne Hultquist; Christopher Famulare; Juan S Medina; Minal A Patel; Qi Gao; Natasha Lewis; Janine Pichardo; Jeeyeon Baik; Brian Shaffer; Sergio Giralt; Raajit Rampal; Sean Devlin; Robert Cimera; Yanming Zhang; Maria E Arcila; Elli Papaemmanuil; Ross L Levine; Mikhail Roshal
Journal:  Blood Adv       Date:  2018-12-11

Review 2.  Somatic SETBP1 mutations in myeloid neoplasms.

Authors:  Hideki Makishima
Journal:  Int J Hematol       Date:  2017-04-26       Impact factor: 2.490

3.  Somatic mutations precede acute myeloid leukemia years before diagnosis.

Authors:  Pinkal Desai; Nuria Mencia-Trinchant; Oleksandr Savenkov; Michael S Simon; Gloria Cheang; Sangmin Lee; Michael Samuel; Ellen K Ritchie; Monica L Guzman; Karla V Ballman; Gail J Roboz; Duane C Hassane
Journal:  Nat Med       Date:  2018-07-09       Impact factor: 53.440

Review 4.  The Role of PHF6 in Hematopoiesis and Hematologic Malignancies.

Authors:  Yusra A Eisa; Ying Guo; Feng-Chun Yang
Journal:  Stem Cell Rev Rep       Date:  2022-08-26       Impact factor: 6.692

5.  Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair.

Authors:  Tsung-Chih Chen; Chi-Yuan Yao; Yu-Ren Chen; Chang-Tsu Yuan; Chien-Chin Lin; Yueh-Chwen Hsu; Po-Han Chuang; Chein-Jun Kao; Yi-Hung Li; Hsin-An Hou; Wen-Chien Chou; Hwei-Fang Tien
Journal:  Oncogene       Date:  2022-01-28       Impact factor: 8.756

6.  C-terminal RUNX1 mutation in familial platelet disorder with predisposition to myeloid malignancies.

Authors:  Kateřina Staňo Kozubík; Lenka Radová; Michaela Pešová; Kamila Réblová; Jakub Trizuljak; Karla Plevová; Veronika Fiamoli; Jaromír Gumulec; Helena Urbánková; Tomáš Szotkowski; Jiří Mayer; Šárka Pospíšilová; Michael Doubek
Journal:  Int J Hematol       Date:  2018-08-06       Impact factor: 2.490

Review 7.  Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AML.

Authors:  Peter Valent; Wolfgang Kern; Gregor Hoermann; Jelena D Milosevic Feenstra; Karl Sotlar; Michael Pfeilstöcker; Ulrich Germing; Wolfgang R Sperr; Andreas Reiter; Dominik Wolf; Michel Arock; Torsten Haferlach; Hans-Peter Horny
Journal:  Int J Mol Sci       Date:  2019-02-12       Impact factor: 5.923

Review 8.  Genetic basis of myelodysplastic syndromes.

Authors:  Seishi Ogawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2020       Impact factor: 3.493

9.  Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes.

Authors:  Yasunobu Nagata; Hideki Makishima; Cassandra M Kerr; Bartlomiej P Przychodzen; Mai Aly; Abhinav Goyal; Hassan Awada; Mohammad Fahad Asad; Teodora Kuzmanovic; Hiromichi Suzuki; Tetsuichi Yoshizato; Kenichi Yoshida; Kenichi Chiba; Hiroko Tanaka; Yuichi Shiraishi; Satoru Miyano; Sudipto Mukherjee; Thomas LaFramboise; Aziz Nazha; Mikkael A Sekeres; Tomas Radivoyevitch; Torsten Haferlach; Seishi Ogawa; Jaroslaw P Maciejewski
Journal:  Nat Commun       Date:  2019-11-26       Impact factor: 17.694

10.  Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design.

Authors:  Almudena Aguilera-Diaz; Iria Vazquez; Beñat Ariceta; Amagoia Mañú; Zuriñe Blasco-Iturri; Sara Palomino-Echeverría; María José Larrayoz; Ramón García-Sanz; María Isabel Prieto-Conde; María Del Carmen Chillón; Ana Alfonso-Pierola; Felipe Prosper; Marta Fernandez-Mercado; María José Calasanz
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.